Skip to main content

LCD L33627: Non-Invasive Vascular Studies

LCD L33627, Non-Invasive Vascular Studies, is the Local Coverage Determination that Wellpoint Federal applies to claims from 13 states (CT, DN, IL, MA, ME, MN, NH, NY and others), effective 2026-04-01 and first in force 2015-10-01. The policy text runs 1,856 words, and its billing and coding article A56758 lists 2,110 ICD-10-CM codes that support medical necessity for 25 procedure codes. 1 other contractor publish a policy with the same title, so the criteria that apply depend on where the service is furnished.

QuickIntell editorial content · Legacy registry date · Review not verified

Data effective
Data currency: Medicare Coverage Database LCD export release of September 24, 2026 (effective September 20, 2026). Next CMS release: weekly (Thursdays) for the MCD.
Contractor
Wellpoint Federal
States and territories
13
CT DN IL MA ME MN NH NY QN RI UN VT WI
Revision effective
2026-04-01
Original effective
2015-10-01
Policy text
1,856 words
Covered ICD-10 codes (articles)
2110

Where this LCD applies

Each contract number is a jurisdiction on the remittance; the policy binds claims processed under these contracts and no others.

Contracts that apply LCD L33627
ContractContractorTypeStates
06101Wellpoint FederalMAC - Part AIL
06201Wellpoint FederalMAC - Part AMN
06301Wellpoint FederalMAC - Part AWI
06102Wellpoint FederalMAC - Part BIL
06202Wellpoint FederalMAC - Part BMN
06302Wellpoint FederalMAC - Part BWI
13101Wellpoint FederalA and B and HHH MACCT
13201Wellpoint FederalA and B and HHH MACNY
13102Wellpoint FederalA and B and HHH MACCT
13202Wellpoint FederalA and B and HHH MACDN
13282Wellpoint FederalA and B and HHH MACUN
13292Wellpoint FederalA and B and HHH MACQN
14411Wellpoint FederalA and B and HHH MACRI
14211Wellpoint FederalA and B and HHH MACMA
14311Wellpoint FederalA and B and HHH MACNH
14511Wellpoint FederalA and B and HHH MACVT
14111Wellpoint FederalA and B and HHH MACME
14112Wellpoint FederalA and B and HHH MACME
14212Wellpoint FederalA and B and HHH MACMA
14312Wellpoint FederalA and B and HHH MACNH
14512Wellpoint FederalA and B and HHH MACVT
14412Wellpoint FederalA and B and HHH MACRI

Billing and coding: diagnoses and procedure codes

Since 2019 the codes live in the companion article rather than the LCD. Billing and Coding A56758 (Billing and Coding: Non-Invasive Vascular Studies) carries the diagnosis and procedure lists the contractor loads as the claims edit. CPT codes are shown as bare numbers because the descriptors are licensed by the AMA; HCPCS Level II descriptors are public and shown.

A56758: Billing and Coding: Non-Invasive Vascular Studies (Billing and Coding, effective 2026-04-01)

Covered ICD-10-CM codes
2110
9 groups
Non-covered ICD-10-CM codes
0
Procedure codes listed
25
Full article
cms.gov record
First 24 covered ICD-10-CM codes in A56758
ICD-10-CMDescription (FY2027)
C22.0—
C22.1—
C22.2—
C22.3—
C22.4—
C22.7—
D57.01—
D57.02—
D57.03—
D57.04—
D57.09—
D57.1—
D57.40—
D57.411—
D57.412—
D57.413—
D57.414—
D57.418—
D57.42—
D57.431—
D57.432—
D57.433—
D57.434—
D57.438—

Procedure codes: 93880, 93882, 93886, 93888, 93892, 93893, 93896, 93897, 93898, 93922, 93923, 93924, 93925, 93926, 93930, 93931, 93970, 93971, 93975, 93976, 93978, 93979, 93985, 93986, 93990.

Coverage indications, limitations and medical necessity

Abstract:

Non-invasive vascular studies utilize ultrasonic Doppler and physiologic principles to assess irregularities in blood flow in arterial and venous systems. The display may be a two dimensional image with spectral analysis and color flow or a plethysmographic recording. For the purposes of this policy, non-invasive vascular studies include duplex scans, physiologic studies and plethysmography.

This local coverage determination specifies NGS policy for non-invasive vascular study testing.

INDICATIONS AND LIMITATIONS:

General Indications:

Non-invasive vascular studies are considered medically necessary if the ordering physician has reasonable expectation that their outcomes will potentially impact the clinical management of the patient. Services are deemed medically necessary when the following conditions are met:

• Significant signs/symptoms of arterial or venous disease are present; and/or

• The information is necessary for appropriate medical and/or surgical management; and/or

• The test is not redundant of other diagnostic procedures that must be performed.

In general, non-invasive studies of the arterial system are utilized when invasive correction is contemplated or when vessels are being harvested for potential use as grafts . It is the responsibility of the physician/provider to ensure the medical necessity of procedures and documentation of such in the medical record.

Credentialing and Accreditation Standards

The accuracy of non-invasive vascular diagnostic studies depends on the knowledge, skill, and experience of the technologist and interpreter. Consequently, the physician performing and/or interpreting the study must be capable of demonstrating documented training and experience and maintain any applicable documentation. A vascular diagnostic study may be personally performed by a physician or a technologist.

The GAO Report to Congressional Committees entitled Medicare Ultrasound Procedures. Consideration of Payment Reforms and Technician Qualifications Requirements states that “Findings from several peer-reviewed studies, the Medicare Payment Advisory Commission, and ultrasound-related professional organizations support requiring that sonographers either have credentials or operate in facilities that are accredited, where specific quality standards apply. In some localities and practice settings, CMS or its contractors have required that sonographers either be credentialed or work in an accredited facility.” (GAO-07-734)

• All non-invasive vascular diagnostic studies must be performed under at least one of the following settings: (1) performed by a physician who is competent in diagnostic vascular studies or under the general supervision of physicians who have demonstrated minimum entry level competency by being credentialed in vascular technology, or (2) performed by a technician who is certified in vascular technology, or (3) performed in facilities with laboratories accredited in vascular technology.

• Examples of appropriate personnel certification include, but are not limited to, the Registered Physician in Vascular Interpretation (RPVI), Registered Vascular Technologist (RVT), the Registered Cardiovascular Technologist (RCVT), Registered Vascular Specialist (RVS), and the American Registry of Radiologic Technologists (ARRT) credentials in vascular technology. Appropriate laboratory accreditation includes the American College of Radiology (ACR) Vascular Ultrasound Program, and the Intersocietal Commission for the Accreditation of Vascular Laboratories (ICAVL).

• Additionally, transcutaneous oxygen tension measurements may be performed by individuals possessing the following credentials obtained from appropriate credentialing bodies, such as, but not limited to, the National Board of Diving and Hyperbaric Medicine Technology (NBDHMT): Certified Hyperbaric Technologist (CHT), or Certified Hyperbaric Registered Nurse (CHRN).

Please Note: 42 CFR Section 410.33, Independent Diagnostic Testing Facilities, requirements that supersede those above. For credentialing requirements please see Billing and Coding: Non-Invasive Vascular Studies (A56758)

General Limitations:

A referral must be on record for each non-invasive study performed. A referral for one type of study does not qualify as a referral for all tests.

Non-invasive vascular studies are considered medically necessary only if the outcome will potentially impact the clinical course of the patient. Non-invasive venous studies may be helpful in in assessing the adequacy of venous conduits, prior to various vascular interventions. However, if the medical records suggest the patient is proceeding directly to angiography or another more potentially definitive study, and the specific rationale for the non-invasive studies is not noted, they will be considered as not medically necessary.

Non-invasive vascular studies include patient care required to perform the studies, supervision of the studies, and interpretation of study results with hard copy output or imaging. Digital storage of imaging is acceptable.

The use of any Doppler device that produces a record that does not permit analysis of bidirectional vascular flow or that does not provide a hard copy printout is part of the physical exam of the vascular system and is not reported separately. ( CPT Expert , 2004, 4th Edition)

It may be necessary to perform simultaneous arterial and venous studies during the same encounter. Documentation must be available to support the medical necessity for both studies.

It is rarely necessary to perform cerebrovascular and upper extremity studies on the same day. Clinical suspicion of extra-cranial carotid disease as justification for pre-operative Doppler studies must be supported in the medical records.

I. Cerebrovascular Arterial Studies

Extracranial Arterial Studies

Covered cerebrovascular arterial study testing methods include (real-time) duplex scans; and Doppler ultrasound waveform with spectral analysis.

Non-covered/non-reimbursed methods include testing methods that have not been found to be useful based on authoritative technological assessments or that are included as part of the physical examination.

Indications:

Cerebrovascular arterial studies may be considered medically necessary if one or more of the following signs and symptoms are present:

• Asymptomatic or symptomatic cervical bruits;

• Amaurosis fugax;

• Focal cerebral or ocular transient ischemic attacks (including but not limited to):

• localizing symptoms, e.g., sensory loss; and/or

• weakness of one side of the face; and/or

• slurred speech; and/or

• weakness of a limb;

• Syncope that is strongly suggestive of vertebrobasilar or bilateral carotid artery disease in etiology, as suggested by medical history;

• Recent history of a previous neurologic or cerebrovascular event;

• Before major cardiac and vascular surgery when a bruit is noted, there is history of previous neurologic or cerebrovascular event, or there is documented clinical suspicion of extracranial carotid occlusion and the rationale for the study is included in the chart;

• After carotid endarterectomy (outside the global period), or follow-up of previously documented stenoses;

• Pulsatile neck mass;

• Evaluation of blunt or penetrating neck trauma;

• Ocular microembolism (optic nerve/retinal arterial-Hollenhorst plaques/ocular);

Limitations:

Studies may not be considered medically necessary if performed for the following signs and symptoms:

• Drop attack or syncope are rare indications usually seen with vertebrobasilar or bilateral carotid artery disease.

• Dizziness is not a typical indication unless associated with other localizing signs or symptoms. However, episodic dizziness with symptom characteristics typical of transient ischemic attacks may indicate medical necessity, especially when other more common sources, e.g., postural hypotension or transiently decreased cardiac output as demonstrated by cardiac event monitoring, have been previously excluded; and/or

• Headaches (including migraines).

Transcranial Doppler (TCD) Studies

Transcranial Doppler (TCD) studies of the intracranial arteries and transcranial duplex imaging of extracranial arteries are approved methods of testing. The presence, location, and extent of disease can be evaluated by utilizing directional pulsed Doppler to estimate flow velocities and assess intracranial vessel hemodynamics and physiology.

Indications:

TCD studies are allowed for the following:

• Detection and evaluation of the hemodynamic effects of severe stenosis or occlusion of the extracranial (greater than or equal to 60% diameter reduction) and major basal intracranial arteries (greater than or equal to 50% diameter reduction);

• Detection and serial evaluation of cerebral vasospasm complicating subarachnoid hemorrhage;

• Evaluation of intracranial hemodynamic abnormalities in patients with suspected brain death;

• Intraoperative and perioperative monitoring of intracranial flow velocity and hemodynamic patterns during carotid endarterectomy, (although the professional component could only be reimbursed if it is provided during the operative procedure by a physician that is not a member of the operating team);

• Evaluation of cerebral embolization; and/or

• Assessing hemodynamic effects, patterns, and extent of collateral circulation in patients with known regions of severe stenosis or occlusion when necessary to care for the patient; and

• Assessing stroke risk in children aged two to sixteen with homozygous sickle cell disease; and

• As an alternative to an echocardiogram to detect residual right to left shunting after repair/closure of an intracardiac or intrapulmonary shunt.

Multiple cerebrovascular procedures may be allowed during the same encounter given the physician/provider can demonstrate medical necessity as documented in the patient’s medical record. For example, physiologic studies and a duplex scan are allowed on the same date of service given the provider is able to document medical necessity, e.g., greater than or equal to 50% stenosis on duplex scan or significant symptoms as demonstrated by the indications for the study.

Limitations:

TCD studies are not indicated for:

• Evaluation of brain tumors;

• Assessment of familial and degenerative disease of the cerebrum, brainstem, cerebellum, basal ganglia and motor neurons;

• Evaluation of infectious and inflammatory conditions;

• Psychiatric disorders; and/or

• Epilepsy.

Transcranial Doppler (TCD) is considered investigational and not medically necessary for the following indications:

• Assessing patients with migraine;

• Monitoring during cardiopulmonary bypass and other cerebrovascular and cardiovascular interventions, and surgical procedures (except during carotid endarterectomy, as noted above);

• Evaluation of patients with dilated vasculopathies such as fusiform aneurysms;

• Assessing autoregulation, physiologic, and pharmacological responses of cerebral arteries; and/or

• Evaluating children with various vasculopathies, such as moyamoya disease and neurofibromatosis.

II. Peripheral Arterial Examinations

Covered peripheral arterial study testing methods include duplex scans; Doppler waveform or spectral analysis; volume, impedance or strain gauge plethysmography; and transcutaneous oxygen tension measurement.

Non-covered peripheral arterial study testing methods include thermography, mechanical oscillometry, inductance or capacitance plethysmography, photoelectric plethysmography, differential plethysmography, and light reflective rheography.

Indications:

Non-invasive peripheral arterial examinations, performed to establish the level and/or degree of arterial occlusive disease, are medically necessary if (1) clinical evidence of limb ischemia is present and (2) the patient is a candidate for invasive/surgical therapeutic interventions. Acute ischemia is often characterized by the sudden onset of severe pain, coldness, numbness and pallor of the extremity. Chronic ischemia can be manifested by intermittent claudication, pain at rest, diminished pulse, ulceration, and gangrene.

A routine history and physical examination, which includes ankle/brachial indices (ABIs), can readily document the presence or absence of ischemic disease in the majority of cases. An ABI is not a reimbursable procedure by itself; rather, ABI may be reimbursed when derived from a more comprehensive procedure which includes a permanent chart copy of the measured pressures and waveforms in the examined vessels.

An ABI should be abnormal, e.g., and accompanied by other appropriate indications before proceeding to additional studies.

Peripheral artery studies may be considered medically necessary if the following signs and symptoms are present:

• Claudication of such severity that it interferes significantly with the patient’s occupation or lifestyle, or claudication with inability to stress the patient;

• Rest pain (typically including the forefoot), usually associated with absent pulses, which becomes increasingly severe with elevation and diminishes with placement of the leg in a dependent position;

• Tissue loss defined as gangrene or pre-gangrenous changes of the extremity, or ischemic ulceration of the extremity occurring in the absence of pulses;

• Aneurysmal disease;

• Evidence of thromboembolic events;

• Blunt or penetrating trauma (including complications of diagnostic and/or therapeutic procedures); and/or

• Follow-up of grafts or other vascular intervention

The policy text continues in the CMS record.

Summary of evidence (opening)

Pursuant to a meeting between NGS staff and clinical directors of three academic cardiovascular programs in Jurisdiction K for a discussion of the literature, and clinical experience with non-invasive vascular imaging at their facilities, the seven recommended articles for discussion are now included in the bibliography. Two of the articles, Taggart and Agrifoglio are persuasive in characterizing the general acceptance of the use of arterial grafts, particularly the radial artery, in the performance of coronary bypass grafting. Lin et al, is an up to date review of the use of carotid duplex ultrasound prior to cardiac surgery reviewing over 3000 cases. The remaining articles are persuasive in the use of ultrasound in the mapping of vessels for hemodialysis, extremity revascularization, and the development of perforator flaps.

the full summary and analysis of evidence are in the CMS record.

Dates, lineage and related policies

Original determination effective
2015-10-01
Current revision effective
2026-04-01
Last reviewed by the contractor
2016-12-16
MCD version
90
Derived from
L27355

The contractor lists one National Coverage Determination as related: NCD 220.5 Ultrasound Diagnostic Procedures. Where an NCD speaks, it controls; the LCD can only address what the NCD leaves open.

Using this policy on a claim

Match the documented indication to the covered indications above before the service is scheduled, carry a diagnosis from the article's covered list on the claim line, and keep the elements the documentation section asks for in the record, because the contractor can request it later through medical review. A denial under this policy arrives as CARC 50 with remark N115; the LCD lookup guide walks through the appeal path and the Advance Beneficiary Notice rules, and the Wellpoint Federal hub lists every other active policy from the same contractor.

The same policy title at other contractors

Contractors often adopt each other's policies and then revise them separately, so the criteria and the diagnosis lists drift apart. The topic comparison lines up every version.

Frequently asked questions

What does LCD L33627 cover?

Non-invasive vascular studies utilize ultrasonic Doppler and physiologic principles to assess irregularities in blood flow in arterial and venous systems. The display may be a two dimensional image with spectral analysis and color flow or a plethysmographic recording. For the purposes of this policy, non-invasive vascular studies include duplex scans, physiologic studies and plethysmography. The full indications and limitations are reproduced on this page from the CMS Medicare Coverage Database export of September 24, 2026.

Which states does LCD L33627 apply to?

Wellpoint Federal applies it to Medicare claims in CT, DN, IL, MA, ME, MN, NH, NY, QN, RI, UN, VT, WI. A Local Coverage Determination binds only the contractor that wrote it; the same service in another jurisdiction is judged under that contractor's own policy or, where none exists, claim by claim.

Which diagnosis codes support medical necessity under LCD L33627?

The companion billing and coding article A56758 lists 2,110 ICD-10-CM codes in 9 groups that support medical necessity; the first 24 appear on this page and the complete list is in the article on cms.gov.

How do I appeal a denial under LCD L33627?

The remittance carries claim adjustment reason code 50 with remark code N115, naming the LCD. Compare the documented indication with the policy's covered indications and the article's diagnosis list, then file a redetermination within 120 days with the record attached; if the service genuinely falls outside the policy, the patient can be billed only when a valid Advance Beneficiary Notice was obtained before the service.

Sources

Every figure on this page is taken from the CMS publications below, as released by the Centers for Medicare & Medicaid Services. Projection built 2026-10-02. Verify against the primary file before billing or contracting decisions.

Disclaimer

The policy text and code lists are reproduced from the CMS Medicare Coverage Database export as an operational reference. Verify against the current LCD and article on cms.gov before billing; coverage depends on the full record and the contractor. Not legal, clinical or billing advice.